VINEETLABNSEVineet Laboratories LimitedMediumNeutral
Announced Mon, 2 Feb · 17:56 IST

We would like to inform that the Rights Issue Committee of the Board of Directors of Vineet Laboratories Limited ( the Company ) has today i.e. February 02, 2026, considered and approved the allotment of 99,87,258 Equity Shares of Face Value of Rs.10/- each on Rights Basis at an issue price of Rs.30/- per Equity Share (including a premium of Rs.20/- per Equity Share).

Corporate Actions View source PDF

VINEETLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Rights Issue Committee of Vineet Laboratories Limited approved the allotment of 99,87,258 equity shares on a rights basis on February 02, 2026. Each share has a face value of Rs. 10 and was issued at Rs. 30 per share, which includes a premium of Rs. 20 per share. This is a follow-up corporate action confirming the completion of the rights share allotment process. The company is raising additional capital from existing shareholders through this rights issue.

Likely market impact

Existing shareholders may see their shareholding pattern change as new shares are allotted, potentially diluting their stake if they did not subscribe. The stock may react based on whether the issue price is at a discount or premium to the prevailing market price, which could affect short-term price movement.